HIPK1 and cardiac hypertrophy: Collectively, these data provide obvious evidence that HIPK1 knockdown exerts a notable beneficial effect to prevent pathological cardiac hypertrophy and suggest that AAV9‐mediated gene therapy is an effective approach to downregulate HIPK1 thus leading to reduced pathological hypertrophy and improved cardiac function in vivo.